Amgen Inc.
AMGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $141 | $154 | $141 | $128 |
| - Cash | $12 | $11 | $8 | $8 |
| + Debt | $61 | $65 | $39 | $34 |
| Enterprise Value | $190 | $208 | $173 | $154 |
| Revenue | $33 | $28 | $26 | $26 |
| % Growth | 18.6% | 7.1% | 1.3% | – |
| Gross Profit | $21 | $20 | $20 | $20 |
| % Margin | 61.5% | 70.1% | 75.7% | 75.2% |
| EBITDA | $13 | $15 | $12 | $11 |
| % Margin | 40% | 52.5% | 46.2% | 43.5% |
| Net Income | $4 | $7 | $7 | $6 |
| % Margin | 12.2% | 23.8% | 24.9% | 22.7% |
| EPS Diluted | 7.56 | 12.49 | 12.11 | 10.28 |
| % Growth | -39.5% | 3.1% | 17.8% | – |
| Operating Cash Flow | $11 | $8 | $10 | $9 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $10 | $7 | $9 | $8 |